Oryzon to Attend the 36th Annual Cowen Health Care Conference

BARCELONA, SPAIN and CAMBRIDGE MA.

Oryzon Genomics (ISIN Code: ES0167733015), a clinical stage biopharmaceutical company leveraging epigenetics to develop therapies in oncology and neurodegenerative diseases, announced today that Dr. Carlos Buesa, Oryzon’s Chief Executive officer, is scheduled to attend the 36th Annual Cowen Health Care Conference on March 7 – 9, 2016 at the Boston Marriott Copley Place.

Click here to see the full Press Release